From Eurofins BioPharma Services

In This Issue:

  • ddPCR in GMP product testing quantifies without calibration curve & determines absolute
    DNA concentration 
  • Coumarin in cosmetics: Clarifying
    the safety controversy
  • Nanomilling for bioavailability enhancement: New capabilities at Eurofins CDMO in North America
  • Eurofins utilises ultrasensitive methods
    in the battle against neurodegeneration
  • Analytical Quality by Design: Eurofins BPT France delivers new level of expertise for methods development
  • Eurofins Biomnis is helping psychiatrists to optimise the choice of antidepressants in
    the treatment of depression
Eurofins Newsletter Product Image 1-1